Survivors of childhood cancer treated with anthracycline chemotherapy or chest radiation
are at an increased risk of developing congestive heart failure. In this population, congestive …

With the advent of multimodality therapy, the overall five-year survival rate from childhood
cancer has improved considerably now exceeding 80% in developed European countries …

Importance Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular
diseases. It is unclear, however, how long the increased risk persists and what the risk …

Purpose To create clinically useful models that incorporate readily available demographic
and cancer treatment characteristics to predict individual risk of heart failure among 5-year …

Purpose Cumulative anthracycline dose is one of the strongest predictors of heart failure
(HF) after cancer treatment. However, the differential risk for cardiotoxicity between …

Background In childhood cancer survivors (CCS) at risk for heart failure, echocardiographic
surveillance recommendations are currently based on anthracyclines and chest-directed …

Standard risk acute lymphoblastic leukemia (SR‐ALL) has high cure rates, but requires 2–3
years of therapy. We aimed to (i) prospectively evaluate health‐related quality of life …

2D (Two-dimensional), 3D (Three-dimensional), ASE (American Society of
Echocardiography), CAC (Coronary artery calcium), CCT (Cardiovascular computed …

Purpose: To examine the utility and reliability of obtaining early echocardiographic
measurements of left ventricular (LV) remodeling as well as blood biomarkers of cardiac …

Opinion statement As chemotherapy continues to improve the lives of patients with cancer,
understanding the effects of these drugs on other organ systems, and the cardiovascular …